help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AGUSTÍ, A. G. N.
Right arrow Articles by RODRIGUEZ-ROISIN, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AGUSTÍ, A. G. N.
Right arrow Articles by RODRIGUEZ-ROISIN, R.
Am. J. Respir. Crit. Care Med., Volume 156, Number 4, October 1997, 1205-1209

Ventilation-Perfusion Mismatch in Patients with Pleural Effusion
Effects of Thoracentesis

ALVAR G. N. AGUSTÍ, JAUME CARDÚS, JOSEP ROCA, JOSEP M. GRAU, ANTONI XAUBET, and ROBERT RODRIGUEZ-ROISIN

Serveis de Pneumologia i Al.lèrgia Respiratòria and Medicina Interna General, Departament de Medicina, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Pleural effusion (PE) often causes abnormal pulmonary gas exchange. Thoracentesis is commonly used to relieve dyspnea in patients with PE, but its effect upon arterial oxygenation is varied and poorly understood. This investigation sought to: (1) characterize the distribution of ventilation-perfusion (V A/Q) ratios in patients with PE and ( 2) assess the effects of PE drainage by thoracentesis upon pulmonary gas exchange. We studied nine patients (two females) with a mean age of 39 ± 20 (SD) yr. All of them had PE of recent clinical onset (< 2 wk of symptoms), without other apparent medical conditions. Before thoracentesis, PaO2 was 82.3 ± 10.2 mm Hg and AaPO2 was 28.7 ± 10.0 mm Hg. Patients had broadened unimodal V A/Q distributions with small amounts of blood flow perfusing lung units with low V A/Q ratios ( < 0.1) (1.4 ± 2.2%) and mild intrapulmonary shunt (6.9 ± 6.7%). PaO2 was significantly related to the amount of shunt (rho = -0.82; p < 0.01) but not to the percentage of blood flow perfusing low V A/Q units. While thoracentesis drained 693 ± 424 ml of fluid and caused a significant fall in mean pleural pressure (by -10.7 ± 7.1 mm Hg; p < 0.01), PaO2, AaPO2, and shunt remained unchanged; only the amount of blood flow perfusing low V A/Q ratios increased slightly (2.4 ± 2.6%; p < 0.05). This study shows that: (1) intrapulmonary shunt is the main mechanism underlying arterial hypoxemia in patients with PE and (2) effective thoracentesis has minor short-term effects upon pulmonary gas exchange. These findings are in accord with delayed (> 30 min) pulmonary volume re-expansion after thoracentesis with or without the coexistence of mild ex vacuo pulmonary edema. Agustí AGN, Cardús J, Roca J, Grau JM, Xaubet A, Rodriguez-Roisin R. Ventilation-perfusion mismatch in patients with pleural effusion: effects of thoracentesis.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Pleural effusion (PE) is a common clinical problem that frequently causes dyspnea and abnormal arterial oxygenation (1). However, the mechanisms underlying this latter effect remain unsettled. Although lung collapse due to the accumulation of pleural fluid is a likely contributor, measurements of pulmonary mechanics in laboratory animals (2) and in patients (3) suggest that the lungs may actually "float" on the PE, an effect that would minimize the impact of atelectasis and subsequent shunting. That the size of the effusion has a small effect on pulmonary gas exchange (4) appears to support this latter hypothesis. To date, however, ventilation-perfusion (VA/Q) distributions in patients with PE have not been adequately characterized. Only a case report (4) has used the multiple inert gas elimination technique (MIGET) (7, 8) to define them appropriately in a single patient.

Alternatively, the drainage of PE by thoracentesis is very effective in relieving dyspnea (1, 9), but its effect upon arterial oxygenation is variable. Pa O2 can improve (10), remain unchanged (13), or deteriorate (14, 15) after drainage. These contrasting findings have been explained on the basis of the presence or absence of concomitant underlying lung parenchymal disease, nature and chronicity of the PE, and/or differences in the technique used to drain it, timing of drainage, or volume drained (10, 15). Nonetheless, its effect upon the VA/Q distributions have not been assessed as yet. In this investigation, we used the MIGET in patients with PE of recent clinical onset to characterize the VA/Q distributions and also to assess their response to the effects of PE drainage by thoracentesis. We hypothesized that pleural effusion would cause regions of intrapulmonary shunt or of low VA/Q, or both, and that the drainage would induce a variable degree of gas exchange improvement, other things being equal.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Patients

We studied nine consecutive patients (two females) with PE of recent clinical onset ( < 2 wk of symptoms). A positive diagnosis of tuberculosis was obtained in six patients, one patient had PE related to rheumatoid arthritis, and the remaining two patients had PE of unknown cause. None of them had cardiac failure or clinical evidence of any other disease, such as chronic obstructive pulmonary disease, asthma, lung fibrosis, and/or liver cirrhosis that could potentially confound pulmonary gas exchange. The main clinical and functional characteristics of the patients are shown in Table 1. There was a moderate restrictive ventilatory defect with a moderate low-transfer factor (DLCO). This study was approved by the Ethics Committee of the Hospital Clinic. All patients gave written consent after being fully informed of the purpose, characteristics, and nature of the study.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1

MAIN CLINICAL AND FUNCTIONAL CHARACTERISTICS OF THE PATIENTS

Study Design

Patients were always studied at the same time of the day (between 9:00 A.M. and 12:00 P.M.). The day of the study, a forced spirometry (Datospir-2000; Siebel-Med, Barcelona, Spain) was obtained in all patients according to ATS recommendations (18). While the patient was sitting comfortably and under steady-state conditions (see below), a complete set of measurements was obtained before and 30 min after draining the PE, according to the following sequence; (1) heart rate and systemic arterial pressure; (2) respiratory frequency and tidal volume; (3) simultaneous arterial blood and mixed expired gas sampling for both inert and respiratory gas determinations; and (4) cardiac output. Thoracentesis was performed in the sitting position, after local anesthesia, using a 18-gauge needle with an internal diameter of 1.2 mm connected to a standard suction machine (A-70; Industrial Ordisi, Barcelona, Spain) through a three-way stopcock. This setup allowed us the direct measurement of pleural pressure (at the level of the fifth intercostal space) before and after withdrawing PE (HP 7754 B recorder; Hewlett Packard, Waltham, MA) (Table 1). Pleural fluid was evacuated at a constant rate of about 150 ml/min until no more fluid could be obtained or the patient showed discomfort (cough, pain, dyspnea). The amount of volume drained and the duration of drainage were recorded and, from these data, drainage flow was calculated (Table 1). Within three h of thoracentesis, a chest roentgenogram was obtained to rule out the presence of pneumothorax, gross pulmonary edema, or other potential abnormalities.

Measurements and Calculations

Blood samples were anaerobically collected through a polyethylene catheter (Seldicath; Plastimed, Saing-Lou-La-Foret, France) inserted into the radial artery of the nondominant hand, after local anesthesia. PaO2, PaCO2, and pH (IL 1302; Izasa, Barcelona, Spain) as well as hemoglobin concentration and oxyhemoglobin saturation (IL 482; Izasa) were analyzed in duplicate. The alveolar-arterial PO2 difference (AaPO2) was calculated according to the standard formula, using the measured respiratory exchange ratio (R). A low-dead space, low-resistance, nonrebreathing valve (No. 1500; Hans Rudolph, Kansas City, MO) connected to a heated metal mixing chamber was used to collect the mixed expired gas. Oxygen uptake (VO2) and CO2 production (VCO2) were calculated from measured mixed expired O2 and CO2 by mass spectrometry (Multigas monitor MS2; BOC-Medishield, London, UK). Minute ventilation (VE) and respiratory rate were measured using a calibrated Wright spirometer (Respirometer MK8; BOC-Medical, Essex, UK). A three-lead EKG, heart rate, and systemic arterial pressure were continuously recorded throughout the study (HP 7830 A monitor and HP 7754 B recorder; Hewlett-Packard). Cardiac output (QT) was measured in duplicate or triplicate using a 5-mg bolus of indocyanine green injected into the peripheral venous line used for inert gas infusion (see below), as previously shown (19). Tracings of dye concentration versus time were derived from a densitometer used in conjunction with a DC-410 cuvette transducer (Waters Instruments Inc., Rochester, NY) at the peripheral artery site. We obtained the distribution of VA/Q ratios using the MIGET, as previously described in our laboratory (19). Briefly, a mixture of six inert gases with different solubilities (sulfurhexafluoride [SF6], ethane, cyclopropane, enflurane, ether, and acetone) dissolved in saline was given at 3 to 5 ml/min through a peripheral vein. Steady-state conditions were assured by monitoring end-tidal PCO2 and PO2, respiratory frequency, tidal volume, heart rate, and systemic arterial pressure kept within ± 5% of variations. Duplicates of arterial blood and mixed expired gas samples were obtained and the concentrations of inert gases were measured (HP 5880 A; Hewlett-Packard) (19). Mixed venous inert partial pressures of each inert gas were calculated from arterial and expired gases using the Fick principle (7, 8, 19). Results of VA/Q indices are the mean of each duplicate.

Statistical Analysis

Results are shown as mean ± SD. The effects of thoracentesis were analyzed using a two-tailed paired t test. Potential correlations between variables of interest were assessed using the Spearman's correlation coefficient (rho). A p value < 0.05 was considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The hemodynamic, ventilatory, and gas exchange data in these patients, before and after thoracentesis, are shown in Table 2. Before thoracentesis, heart rate, mean systemic arterial pressure, QT, VE, respiratory rate, VO2, and VCO2 were within the normal range. Mean PaO2 (range: 69 to 104 mm Hg), PaCO2, and pH were also within normal limits (Table 2); the AaPO2 was slightly increased (range: 9 to 46 mm Hg). A representative VA/Q distribution in one of the patients studied is illustrated in Figure 1. All subjects had broadened unimodal VA/Q distributions, with small amounts of blood flow perfusing units with low VA/Q ratios ( < 0.1, excluding shunt) (1.4 ± 2.2%; range: 0% to 6%). The former abnormality caused an increased dispersion of the perfusion distribution (LogSD Q), whose mean value was 0.72 ± 0.29 (normal values < 0.6) (19) (range: 0.33 to 1.32). Besides, most of them had mild intrapulmonary shunt (VA/Q ratios < 0.005: 6.9 ± 6.7%; range: 0% to 23%). The ventilation distribution was normal. Predicted PaO2 (from the degree of both shunting and VA/Q mismatch) and measured Pa O2 were not significantly different, indicating no impairment in the diffusion of O2 from the alveolar air to the capillary blood (20). The degree of arterial hypoxemia before thoracentesis was significantly related to the intrapulmonary shunt value (rho -0.82; p < 0.01) but did not correlate (rho = -0.40) with the amount of blood flow perfusing lung units with low VA/Q ratios ( < 0.1).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2

HEMODYNAMIC, VENTILATORY, AND GAS  EXCHANGE MEASUREMENTS


View larger version (14K):
[in this window]
[in a new window]
 
Figure 1.   Distribution of ventilation-perfusion (VA/Q) ratios in a representative patient, before ( left panel ) and after (right panel ) thoracentesis. For further explanation, see text.

There were no clinical complications associated with thoracentesis. The mean volume of pleural fluid drained was 693 ± 424 ml. In seven patients, there was a noticeable change in chest X-ray after thoracentesis. However, all patients still showed some evidence of PE after thoracentesis. Pleural pressure fell significantly after thoracentesis (from 3.6 ± 7.2 to -7.1 ± 13.0 mm Hg; p < 0.01) (Table 1). Yet, most of the other physiologic variables remained unchanged (Table 2). In particular, neither PaO2 nor AaPO2 varied after thoracentesis. As shown in Figure 2, PaO2 after thoracentesis increased in four patients, decreased in four others, and remained unchanged in one; in absolute terms, however, changes were of small magnitude. Similarly, the amount of intrapulmonary shunt did not vary significantly after thoracentesis (Table 2, Figure 2). In contrast, the perfusion of low VA/Q units increased slightly in the majority of patients (p < 0.05), although, in absolute terms, changes were again of small magnitude (Figure 1). Likewise, the dispersion of the blood flow distribution (LogSD Q) mildly worsened after thoracentesis in most patients (Table 2, Figure 2). Changes in pulmonary gas exchange variables (PaO2, AaPO2, shunt, and/or LogSD Q) after thoracentesis did not correlate with the fall in pleural pressure (Figure 3), the volume drained, the timing of drainage, and/or flow of drainage. Also, predicted PaO2 and measured PaO2 were close after thoracentesis, again suggesting the lack of alveolar-capillary diffusion limitation or post-pulmonary shunt as factors explaining arterial hypoxemia. The remaining sum of squares (RSQ) in the present study was 2.4 ± 1.5 (range: 0.65 to 6.8).


View larger version (25K):
[in this window]
[in a new window]
 
Figure 2.   Individual and mean (solid bars) values of several pulmonary gas exchange variables before and 30 min after draining pleural effusion by thoracentesis. For further explanation, see text.


View larger version (11K):
[in this window]
[in a new window]
 
Figure 3.   Correlation between the change in pleural pressure seen after thoracentesis (bottom axes) and several indices of pulmonary gas exchange (n = 8). For further explanation, see text.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Our study demonstrates that intrapulmonary shunt is the principal mechanism underlying defective arterial oxygenation in patients with PE of recent clinical onset and that thoracentesis caused very small short-term (within 30 min) changes in pulmonary gas exchange, despite the relatively large amounts of PE drained and the significant fall in pleural pressure induced. Only the amount of blood flow perfusing low VA/Q units, hence that of Log SD Q, increased significantly after thoracentesis. However, this change was of small magnitude and did not influence arterial oxygenation. These observations, though, apply to the particular patients studied herein and may not be readily extrapolated to patients with chronic PE.

Several studies have investigated the effects of PE on pulmonary gas exchange (5, 11, 12, 15, 21), but only a single case report (4) unraveled the underlying mechanisms using the MIGET to characterize the distribution of VA/Q ratios. Our study extends this case report to a group of patients with PE of recent clinical onset, carefully selected to avoid potential confounding clinical factors. Our results show that VA/Q distributions in these patients are characterized by the presence of mild intrapulmonary shunt and the virtual absence of areas with low VA/Q units, likely related to different degrees of lung collapse caused by the accumulation of fluid in the pleural cavity. Further, we observed that the degree of arterial hypoxemia was significantly related to the value of shunt but not to the amount of blood flow perfusing low VA/Q units. These findings demonstrate that the main mechanism underlying abnormal oxygenation in patients with PE is the presence of intrapulmonary shunt.

Drainage of PE by thoracentesis is a common procedure in clinical practice to alleviate dyspnea (1). Yet, there is controversy concerning its effects upon arterial oxygenation because Pa O2 can improve (10), remain unchanged (13), or deteriorate (14, 15) after it. The presence of other concurrent cardiopulmonary diseases, the etiology and timing of the PE, and/or methodologic differences have been quoted as potential mechanisms/factors to explain these conflicting findings (10, 15). We selected our patients to avoid some of these potential biases. Further, this is the first study that has used the MIGET to assess the effects of thoracentesis upon the distribution of VA/Q ratios. In our patients, despite the relatively large amounts of PE drained and the significant fall in pleural pressure induced by thoracentesis, neither Pa O2, AaPO2, or shunt changed significantly 30 min after thoracentesis. By contrast, the percentage of blood flow perfusing poorly ventilated lung units increased in most patients, although changes were small in absolute terms and not related to the volume of pleural fluid drained, the timing of drainage, and/or the drainage flow. Collectively, these observations admit, as least, three different explanations.

Firstly, re-expansion of the lung after thoracentesis may not be immediate (11, 12, 22). When fluid is aspirated from the thoracic cavity, the net gain of pulmonary volume is set by the balance between the compliance of the lung parenchyma and that of the thoracic cavity (11). Therefore, the amount of pleural fluid drained by thoracentesis does not necessarily reflect the net gain in lung volume after the procedure (9, 22). In fact, previous studies reported a lack of relationship between the volume of pleural fluid drained and changes in arterial oxygenation (11, 12). We cannot prove this hypothesis because, unfortunately, we did not have sequential VA/Q or lung volume measurements over a period of a few hours after thoracentesis. However, pleural pressure became quite negative after thoracentesis without a parallel change in LogSD Q (Figure 3), hence indicating that the underlying lung was not expanding after drainage.

Secondly, previous studies of lung mechanics in patients with PE have suggested that the lung actually floats in the fluid of the pleural cavity, hence minimizing the impact of pulmonary collapse (2). If this was true, effective drainage of PE by thoracentesis should be expected to cause small changes in the distribution of VA/Q ratios despite reducing the pleural pressure significantly, as it actually occurred.

Thirdly, an alternative mechanism invoked to explain impaired arterial oxygenation after thoracentesis is the development of ex vacuo pulmonary edema (14, 15, 22). Although the increase in the percentage of blood flow perfusing low VA/Q units ( < 0.1) after thoracentesis is compatible with this phenomenon, the lack of change in intrapulmonary shunt after the procedure does not seemingly support this contention; further, the chest roentgenogram obtained after the study did not show the presence of alveolar infiltrates suggestive of pulmonary edema. However, our results cannot rule out completely this potential additional mechanism. Unfortunately, other types of information that may have potentially provided relevant data on this subject, such as a CT scan after thoracentesis, were not available.

In summary, this study shows that mild intrapulmonary shunt is the cardinal mechanism underlying arterial hypoxemia in patients with PE and that thoracentesis increases slightly the amount of blood flow perfusing low VA/Q units in the short term. Yet, the latter finding appears to be dissociated from the volume of pleural fluid drained, the timing of drainage, or the drainage flow. This is compatible with delayed pulmonary volume re-expansion after thoracentesis with or without the hypothesis of mild ex vacuo pulmonary edema developing after thoracentesis.

    Footnotes

Correspondence and requests for reprints should be addressed to Dr. J. Roca, Servei Pneumologia i Al.lèrgia Respiratòria, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain.

(Received in original form December 13, 1996 and in revised form May 21, 1997).

   Dr. Agustí's present address is Servei de Pneumologia, Hospital Universitari Son Dureta, Palma Mallorca, Spain.

Acknowledgments: The writers thank the technical staff of the Gabinet de Funció Pulmonar of the Servei de Pneumologia i Al.lèrgia Respiratòria (Hospital Clinic, Barcelona) for their help during the study and to J. Gea, M.D., for his unselfish input at the inception of the study.

Supported in part by Grant 96/0897 from the Fondo de Investigación Sanitaria (FIS) and the Commissionat per a Universitats i Recerca de la Generalitat de Catalunya (1995-SGR-00446).

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Light, R. W. 1995. Pleural Diseases. Williams & Wilkins, Baltimore.

2. Krell, W. S., and J. R. Rodarte. 1985. Effects of acute pleural effusion on respiratory system mechanics in dogs. J. Appl. Physiol. 59: 1458-1463 [Abstract/Free Full Text].

3. Anthonisen, N. R., and R. R. Martin. 1977. Regional lung function in pleural effusion. Am. Rev. Respir. Dis. 116: 201-207 [Medline].

4. Gillespie, D. J., and K. Rehder. 1989. Effect of positional change on ventilation-perfusion distribution in unilateral pleural effusion. Intensive Care Med. 15: 266-268 [Medline].

5. Sonnenblick, M., E. Melzer, and A. J. Rosin. 1983. Body positional effect on gas exchange in unilateral pleural effusion. Chest 83: 784-786 [Abstract/Free Full Text].

6. Yoo, O. H., and E. Y. Ting. 1964. The effects of pleural effusion on pulmonary function. Am. Rev. Respir. Dis. 89: 55-63 .

7. Wagner, P. D., P. F. Naumann, R. B. Laravuso, and J. B. West. 1974. Simultaneous measurement of eight foreign gases in blood by gas chromatography. J. Appl. Physiol. 36: 600-605 [Free Full Text].

8. Evans, J. W., and P. D. Wagner. 1977. Limits on ·VA/Q distributions from analysis of experimental inert gas elimination technique. J. Appl. Physiol. 42: 889-898 [Abstract/Free Full Text].

9. Estenne, M., J. C. Yernault, and A. de Troyer. 1983. Mechanism of relief of dyspnea after thoracentesis in patients with large pleural effusions. Am. J. Med. 74: 813-819 [Medline].

10. Neff, T. A., and B. D. Buchanan. 1975. Tension pleural effusion. Am. Rev. Respir. Dis. 111: 543-548 [Medline].

11. Brown, N. E., N. Zamel, and A. Aberman. 1978. Changes in pulmonary mechanics and gas exchange following thoracocentesis. Chest 74: 540-542 [Abstract/Free Full Text].

12. Perpiñá, M., E. Benlloch, V. Marco, F. Abad, and D. Nauffal. 1983. Effects of thoracocentesis on pulmonary gas exchange. Thorax 38: 747-750 [Abstract/Free Full Text].

13. Karetzky, M. S., G. A. Kothari, J. A. Fourre, and A. U. Khan. 1978. Effects of thoracocentesis on arterial oxygen tension. Respiration 36: 96-103 [Medline].

14. Trapnell, D. H., and J. G. B. Thurston. 1970. Unilateral pulmonary oedema after pleural aspiration. Lancet 661: 1367-1369 .

15. Brandstetter, R. D., and R. P. Cohen. 1979. Hypoxemia after thoracocentesis: a predictable and treatable condition. J.A.M.A. 242: 1060-1061 [Abstract/Free Full Text].

16. Roca, J., J. Sanchis, A. Agustí-Vidal, J. Segarra, D. Navajas, R. Rodriguez-Roisin, P. Casan, and S. Sans. 1986. Spirometric reference values for a mediterranean population. Bull Eur. Physiopathol. Respir. 22: 217-224 [Medline].

17. Roca, J., R. Rodriguez-Roisin, E. Cobo, F. Burgos, J. Pérez, and J. L. Clausen. 1990. Single-breath carbon monoxide diffusing capacity (DLCO) prediction equations for a mediterranean population. Am. Rev. Respir. Dis. 141: 1026-1032 [Medline].

18. American Thoracic Society. 1995. Standardization of spirometry. 1994 update. Am. J. Respir. Crit. Care Med. 152: 1107-1136 [Medline].

19. Roca, J., and P. D. Wagner. 1994. Contribution of the multiple inert gas elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique. Thorax 49: 815-824 [Abstract/Free Full Text].

20. Agustí, A. G. N., J. Roca, R. Rodriguez-Roisin, J. Gea, A. Xaubet, and P. D. Wagner. 1991. Mechanisms of gas exchange impairment in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143: 219-225 [Medline].

21. Gillespie, D. J., and K. Rehder. 1987. Body position and ventilation-perfusion relationships in unilateral pulmonary disease. Chest 91: 75-79 [Abstract/Free Full Text].

22. Doerschuk, C. M., M. F. Allard, and M. J. Oyarzún. 1990. Evaluation of reexpansion pulmonary edema following unilateral pneumothorax in rabbits and the effect of superoxide dismutase. Exp. Lung Res. 16: 355-367 [Medline].





This article has been cited by other articles:


Home page
ChestHome page
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash
Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 368S - 403S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Doelken, R. Abreu, S. A. Sahn, and P. H. Mayo
Effect of thoracentesis on respiratory mechanics and gas exchange in the patient receiving mechanical ventilation.
Chest, November 1, 2006; 130(5): 1354 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. J. de Waele, E. Hoste, D. Benoit, K. Vandewoude, S. Delaere, F. Berrevoet, and F. Colardyn
The Effect of Tube Thoracostomy on Oxygenation in ICU Patients
J Intensive Care Med, March 1, 2003; 18(2): 100 - 104.
[Abstract] [PDF]


Home page
ChestHome page
P. A. Kvale, M. Simoff, and U. B. S. Prakash
Palliative Care
Chest, January 1, 2003; 123 (2009): 284S - 311S.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Dakin and M Griffiths
The pulmonary physician in critical care 1: Pulmonary investigations for acute respiratory failure
Thorax, January 1, 2002; 57(1): 79 - 85.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. W. Pien, M. J. Gant, C. L. Washam, and D. H. Sterman
Use of an Implantable Pleural Catheter for Trapped Lung Syndrome in Patients With Malignant Pleural Effusion
Chest, June 1, 2001; 119(6): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. J. Krowka, G. A. Wiseman, O. L. Burnett, J. R. Spivey, T. Therneau, M. K. Porayko, and R. H. Wiesner
Hepatopulmonary Syndrome : A Prospective Study of Relationships Between Severity of Liver Disease, PaO2 Response to 100% Oxygen, and Brain Uptake After 99mTc MAA Lung Scanning
Chest, September 1, 2000; 118(3): 615 - 624.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M J KROWKA
Hepatopulmonary syndromes
Gut, January 1, 2000; 46(1): 1 - 4.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AGUSTÍ, A. G. N.
Right arrow Articles by RODRIGUEZ-ROISIN, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AGUSTÍ, A. G. N.
Right arrow Articles by RODRIGUEZ-ROISIN, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society